Skip to main content
. Author manuscript; available in PMC: 2014 Mar 15.
Published in final edited form as: Clin Cancer Res. 2013 Feb 26;19(6):1620–1627. doi: 10.1158/1078-0432.CCR-12-3115

Table 1.

CD33 SNPs identified by sequencing and genotyped in the present study.

CD33 SNP rs# Location Allele Frequency Flanking sequence
Leu10Leu rs117255828 Exon 1 T=0.02 GCTGCCCCTG-C-TGTGGGCAGG
Ala14Val rs12459419 Exon 2 T=0.31 CCCACAGGGG-C-CCTGGCTATG
Arg62Glu Exon 2 A=0.005 TACTGGTTCC-G-GGAAGGAGCC
Ala65Pro Exon 2 C=0.005 CCGGGAAGGA-G-CCATTATATC
Arg69Gly rs2455069 Exon 2 G=0.4 CCATTATATCC-A-GGGACTCTCC
Phe243Leu rs11882250 Exon 4 C=0.01 AACTGGTATC-T-TTCCAGGAGA
Val267Ile rs58981829 Exon 5 A=0.02 AGGAGCTGGT-G-TTACAGCCCT
Arg304Gly rs35112940 Exon 6 A=0.13 CCCTACCACA-G-GGTCAGCCTC
Ser305Pro rs61736475 Exon 6 C=0.04 TACCACAGGG-T-CAGCCTCCCC
Ala331Thr rs35632246 Exon 7 G=0.004 TGCCGCCCCT-A-CTGTGGAGAT
intron 6 rs273621 Intron 6 (Splice site) C=0.01 GCCTCCCCGG-T-GAGTGATGGG
3′UTR rs1803254 3′UTR C=0.22 CATTTGCTAA-G-TGTATGATGT

SNPs in bold occur with minimum allele frequency (MAF) of more than 0.1 were selected for genotyping.